FIP recognises MPS-YPC in training leadership for pharmacists.

By Sally Ng
A pharmacist by profession, an explorer by nature

We are very honor to be mentioned byInternational Pharmaceutical Federation (FIP)Education report as one of the bodies along with#MPS and Malaysian Pharmacy Students’ Association (MyPSA) in training leadership for pharmacists. We are grateful to all authors for this comprehensive report! We will do our level best in nurturing the next generation of pharmacy leaders.
The full report can be found at https://fip.org/
Related
YPC Live Podcast #1: Workplace Communication
Last updated onWith new digital technologies growing increasingly involved in contemporary healthcare, an upcoming symposium aims to place the implications for patient welfare at the centre of the discussion. This October, the third edition of the Malaysian Innovative Healthcare Symposium 2018 (MIHS 2018) will bring together healthcare professionals to explore the potential of current and upcoming…
Malaysian Clinical Pharmacy Symposium (MCPS) 2.5
Last updated onWritten by Tang Jia Wen, commitee member of MCPS 2.5 On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…
World Pharmacists Day 2018 (20-21 October 2018)
Last updated onEvent: World Pharmacists Day 2018 Date: 20-21 October 2018 (Saturday and Sunday) Time: 10am – 10pm daily Venue: MyTown, Cheras, Kuala Lumpur Theme: Pharmacists, Your Medicines Expert Organised by Pharmaceutical Services Program Ministry of Health, ATM Ministry of Defense, MPS, MCPG, PhAMA, MOPI
Meet ‘Maya’ – Your New BFF for Family Planning
Last updated onWorld Pharmacists Day (WPD) 2018
Last updated onOthers
WHO to look into drug pricing?
Last updated onOur health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…
Abolishment of Critical Allowance: What, Why, and How now?
Last updated onWritten by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast. What? The critical allowance, or more commonly known as Bayaran Insentif Perkhidmatan Kritikal (BIPK) was a fund started in 1992 for jobs which fulfilled 2 criteria: 1) The job has low remuneration 2)…
Coronavirus Declared as Global Emergency by WHO
Last updated onThe recent coronavirus outbreak took us by surprise. This storm came as sudden as a midnight deluge, and it seems like it is here to stay. Admittedly, even I myself am wearing a mask as I type this. What seem to otherwise be commonplace items such as face masks and hand sanitizers are now scarce…
MPS-REGISTRATION FORM for MPS-CPDOnLine (Non MPS Member)
Last updated onMPS Ordinary, Postgraduate, Associate Members (with Sub Paid Up Year 2018), Life and Fellow Members are automatically enrolled into the system. No further action is require to access the system. MPS Members will also be able to access the Academy of Pharmacy E-Learning Programme website (www.acadpharm.org.my) besides the CPD-Online website (www.mps.org.my/cpdonline) with the same login…
Manifesto MPS – Voices of Pharmacists
Last updated onDear fellow pharmacists, It is our duty as one of the 16,300 registered pharmacists to spread this message for the Malaysian General Elections 14 to be held on 9th May 2018. MPS has done it’s part to create this manifesto for the sake of the rakyat and the profession. We hope the in-coming government will…
Recall of Losartan
Last updated onOn early March, the Ministry of Health Malaysia released a statement regarding the recall of 7 types of medication containing the active ingredient Losartan. This came about after some of these angiotension II receptor blocker (ARB) were found to contain unacceptable amount of nitrosamine, a substance which is possibly carcinogenic, or has the potential to…